Korro Bio's total assets for Q4 2024 were $226.24M, a decrease of -7.10% from the previous quarter. KRRO total liabilities were $65.83M for the fiscal quarter, a 2.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.